DaVita Inc. DVA, announced that it has entered into a definitive agreement to acquire DSI Renal, Inc., for approximately $690 million, subject to adjustments. The company expects to close the transaction in the second or third quarter of this year.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in